FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
Changhoon Yoo(Ulsan College), Baek‐Yeol Ryoo(Asan Medical Center), Ki Byung Song(Ulsan College), Myung‐Hwan Kim(Korea Aerospace Research Institute), Dae Wook Hwang(Asan Medical Center), Sung Koo Lee(Ulsan College), Kyu‐pyo Kim(Ulsan College), Dong Wan Seo(Dankook University), Jae Ho Byun(University of Ulsan), Song Cheol Kim(Ulsan College), Tae Jun Song, Jae Hoon Lee(Ulsan College), Sang Soo Lee(Chungbuk National University Hospital), Jin‐hong Park, Jae Ho Jeong(Ulsan College), Inhwan Hwang(Ulsan College), Woohyung Lee(Ulsan College), Heung-Moon Chang(Asan Medical Center), Do Hyun Park(Massachusetts Institute of Technology)
Cited by 35
Related Papers
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
|Journal of Clinical Oncology|2019|1.8k
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
TIMP-2 Mediated Inhibition of Angiogenesis
|Cell|2003|510
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472